Market Overview:
MicroRNA consumables market is expected to witness a CAGR of 10.8% during the forecast period from 2018 to 2030. The global microRNA consumables market was valued at US$ 1,362.5 Mn in 2017 and is projected to reach US$ 3,746.4 Mn by 2030, expanding at a CAGR of 10.8% from 2018 to 2030. The global microRNA consumables market has been segmented on the basis of type, application and region. On the basis of type, the global microRNA consumables market has been segmented into isolation & purification, quantification & detection, functional analysis and others segments. The isolation & purification segment is estimated to account for major share in terms of revenue in 2018 and is projected to maintain its dominance throughout the forecast period from 2018 to 2030 owing high adoption rates across various applications such as cancer research laboratories, infectious diseases research laboratories etc., followed by quantification & detection segment due high demand for accurate quantitation results for downstream analysis purposes such as biomarker discovery/validation studies etc., Functional analysis held third largest revenue share in 2017 and it would continue through 2021 owing rising popularity for miRNAs as therapeutic targets across various indications such as cancer immunotherapy etc., whereas other segments are anticipated exhibit highest growth rate over the forecast period due increasing R&D investments towards development of novel technologies that can offer better performance characteristics over traditional methods currently used worldwide.
Product Definition:
MicroRNA Consumables are materials that can be used to isolate, detect and quantify microRNAs. They are important for studying the role of microRNAs in various biological processes.
Isolation & Purification:
Isolation & purification is a process to get specific components from a mixture. It's majorly used for RNA extraction and library construction. In the case of DNA, it's used for PCR setup and preparation of sample for sequencing.
Quantification & Detection:
Quantification and detection are the two most important aspects of microRNA consumables. These two aspects work together to provide accurate, reliable and sensitive results for researchers. The quantification aspect provides real-time measurement of small RNA molecules while detection aspect helps in the identification of different types of small RNAs with various targets by providing them a unique code.
Application Insights:
The cancer segment dominated the global market in terms of revenue and is expected to continue its dominance over the forecast period. This can be attributed to growing awareness about microRNA functions during tumorigenesis, increasing investment by governments in R&D for cancer treatment, and rising demand for microRNA-based therapeutics.
miRNAs have been proven effective against a wide range of cancers including lung, breast, colon/rectal, stomach/pharynx/laryngotracheal (LTT) tumors as well as leukemia. In addition, they are also being studied for their potential use against other types of cancer such as skin carcinoma and bone metastasis which has led to an increase in product demand across the globe.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of micro RNA (miRNA) research laboratories, increase in funding by government and private entities for miRNA-based therapeutics and diagnostic products, as well as high prevalence of chronic diseases such as cancer, cardiovascular disease (CVD), infectious diseases including HIV/AIDS and others. Moreover, increasing awareness about emerging technologies among researchers is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as growing interest towards emerging markets by pharmaceutical companies due to low cost associated with labor; availability of raw materials; proximity from manufacturing hubs; rapid economic development coupled with improvement in healthcare infrastructure are some other drivers responsible for its fastest growth rate during the projected period. Furthermore, rising incidence rates related to various types of cancers are also expected fuel this regional market demand over next eight years.
Growth Factors:
- Increasing demand for personalized medicines
- Growing application of microRNA in drug discovery and development processes
- Rising prevalence of chronic diseases
- Technological advancements in microRNA detection and analysis tools
- Growing investments by pharmaceutical and biotechnology companies in microRNA research
Scope Of The Report
Report Attributes
Report Details
Report Title
MicroRNA Consumables Market Research Report
By Type
Isolation & Purification, Quantification & Detection, Functional Analysis, Others
By Application
Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others
By Companies
Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., BioGenex, SeqMatic LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global MicroRNA Consumables Market Report Segments:
The global MicroRNA Consumables market is segmented on the basis of:
Types
Isolation & Purification, Quantification & Detection, Functional Analysis, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermofisher Scientific (Life Technologies)
- Agilent Technologies
- Merck KGaA
- QIAGEN (Exiqon)
- NanoString Technologies, Inc.
- Dharmacon (Horizon Discovery Group)
- Synlogic
- GeneCopoeia, Inc.
- New England Biolabs
- Quantabio
- NanoString Technologies, Inc.
- BioGenex
- SeqMatic LLC
Highlights of The MicroRNA Consumables Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Isolation & Purification
- Quantification & Detection
- Functional Analysis
- Others
- By Application:
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the MicroRNA Consumables Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
MicroRNA consumables are small RNA molecules that can be used to modulate gene expression.
Some of the major companies in the microrna consumables market are Thermofisher Scientific (Life Technologies), Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., BioGenex, SeqMatic LLC.
The microrna consumables market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 MicroRNA Consumables Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 MicroRNA Consumables Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 MicroRNA Consumables Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the MicroRNA Consumables Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global MicroRNA Consumables Market Size & Forecast, 2018-2028
4.5.1 MicroRNA Consumables Market Size and Y-o-Y Growth
4.5.2 MicroRNA Consumables Market Absolute $ Opportunity
Chapter 5 Global MicroRNA Consumables Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 MicroRNA Consumables Market Size Forecast by Type
5.2.1 Isolation & Purification
5.2.2 Quantification & Detection
5.2.3 Functional Analysis
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global MicroRNA Consumables Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 MicroRNA Consumables Market Size Forecast by Applications
6.2.1 Cancer
6.2.2 Infectious Diseases
6.2.3 Immunological Disorder
6.2.4 Cardiovascular Disease
6.2.5 Neurological Disease
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global MicroRNA Consumables Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 MicroRNA Consumables Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America MicroRNA Consumables Analysis and Forecast
9.1 Introduction
9.2 North America MicroRNA Consumables Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America MicroRNA Consumables Market Size Forecast by Type
9.6.1 Isolation & Purification
9.6.2 Quantification & Detection
9.6.3 Functional Analysis
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America MicroRNA Consumables Market Size Forecast by Applications
9.10.1 Cancer
9.10.2 Infectious Diseases
9.10.3 Immunological Disorder
9.10.4 Cardiovascular Disease
9.10.5 Neurological Disease
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe MicroRNA Consumables Analysis and Forecast
10.1 Introduction
10.2 Europe MicroRNA Consumables Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe MicroRNA Consumables Market Size Forecast by Type
10.6.1 Isolation & Purification
10.6.2 Quantification & Detection
10.6.3 Functional Analysis
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe MicroRNA Consumables Market Size Forecast by Applications
10.10.1 Cancer
10.10.2 Infectious Diseases
10.10.3 Immunological Disorder
10.10.4 Cardiovascular Disease
10.10.5 Neurological Disease
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific MicroRNA Consumables Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific MicroRNA Consumables Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific MicroRNA Consumables Market Size Forecast by Type
11.6.1 Isolation & Purification
11.6.2 Quantification & Detection
11.6.3 Functional Analysis
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific MicroRNA Consumables Market Size Forecast by Applications
11.10.1 Cancer
11.10.2 Infectious Diseases
11.10.3 Immunological Disorder
11.10.4 Cardiovascular Disease
11.10.5 Neurological Disease
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America MicroRNA Consumables Analysis and Forecast
12.1 Introduction
12.2 Latin America MicroRNA Consumables Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America MicroRNA Consumables Market Size Forecast by Type
12.6.1 Isolation & Purification
12.6.2 Quantification & Detection
12.6.3 Functional Analysis
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America MicroRNA Consumables Market Size Forecast by Applications
12.10.1 Cancer
12.10.2 Infectious Diseases
12.10.3 Immunological Disorder
12.10.4 Cardiovascular Disease
12.10.5 Neurological Disease
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) MicroRNA Consumables Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) MicroRNA Consumables Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) MicroRNA Consumables Market Size Forecast by Type
13.6.1 Isolation & Purification
13.6.2 Quantification & Detection
13.6.3 Functional Analysis
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) MicroRNA Consumables Market Size Forecast by Applications
13.10.1 Cancer
13.10.2 Infectious Diseases
13.10.3 Immunological Disorder
13.10.4 Cardiovascular Disease
13.10.5 Neurological Disease
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 MicroRNA Consumables Market: Competitive Dashboard
14.2 Global MicroRNA Consumables Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermofisher Scientific (Life Technologies)
14.3.2 Agilent Technologies
14.3.3 Merck KGaA
14.3.4 QIAGEN (Exiqon)
14.3.5 NanoString Technologies, Inc.
14.3.6 Dharmacon (Horizon Discovery Group)
14.3.7 Synlogic
14.3.8 GeneCopoeia, Inc.
14.3.9 New England Biolabs
14.3.10 Quantabio
14.3.11 NanoString Technologies, Inc.
14.3.12 BioGenex
14.3.13 SeqMatic LLC
